Viraga Laxmidhar Haridas, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Image Cytometry | 1 | 2016 | 54 | 0.540 |
Why?
|
Toxoplasma | 1 | 2016 | 157 | 0.490 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 1 | 2015 | 61 | 0.480 |
Why?
|
Flow Cytometry | 4 | 2016 | 5870 | 0.330 |
Why?
|
Mycobacterium tuberculosis | 2 | 2016 | 1914 | 0.310 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1459 | 0.290 |
Why?
|
Antitubercular Agents | 1 | 2015 | 1375 | 0.270 |
Why?
|
Anti-Retroviral Agents | 1 | 2015 | 1784 | 0.240 |
Why?
|
Antigens, Differentiation | 2 | 2016 | 909 | 0.210 |
Why?
|
T-Lymphocytes | 4 | 2015 | 10194 | 0.210 |
Why?
|
RNA, Small Interfering | 4 | 2016 | 3430 | 0.200 |
Why?
|
Software | 1 | 2016 | 4434 | 0.200 |
Why?
|
Tuberculosis | 1 | 2015 | 2017 | 0.200 |
Why?
|
Lymphotoxin-alpha | 1 | 2020 | 93 | 0.180 |
Why?
|
Phagocytosis | 3 | 2016 | 1528 | 0.120 |
Why?
|
Cambodia | 1 | 2015 | 185 | 0.120 |
Why?
|
Luminescent Proteins | 1 | 2016 | 837 | 0.110 |
Why?
|
Genes, Reporter | 1 | 2016 | 1529 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2016 | 1085 | 0.100 |
Why?
|
HIV Infections | 3 | 2015 | 17354 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2020 | 4352 | 0.090 |
Why?
|
Immunophenotyping | 1 | 2015 | 1869 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2010 | 178 | 0.080 |
Why?
|
Gene Expression | 2 | 2020 | 7581 | 0.080 |
Why?
|
Cytokines | 3 | 2015 | 7396 | 0.080 |
Why?
|
Dendritic Cells | 2 | 2010 | 2747 | 0.080 |
Why?
|
Vaccinia | 1 | 2008 | 71 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1903 | 0.080 |
Why?
|
Listeriosis | 2 | 2008 | 149 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4369 | 0.070 |
Why?
|
Dengue Virus | 1 | 2009 | 201 | 0.070 |
Why?
|
Listeria monocytogenes | 2 | 2008 | 249 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1898 | 0.070 |
Why?
|
Dengue | 1 | 2009 | 254 | 0.070 |
Why?
|
Monocytes | 1 | 2015 | 2570 | 0.070 |
Why?
|
Membrane Proteins | 2 | 2015 | 7859 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2015 | 3677 | 0.050 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2010 | 1784 | 0.050 |
Why?
|
HIV | 1 | 2010 | 1582 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2008 | 1359 | 0.050 |
Why?
|
RNA Interference | 1 | 2008 | 2832 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 2 | 2020 | 1844 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11904 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1055 | 0.040 |
Why?
|
Conserved Sequence | 1 | 2020 | 1163 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2020 | 539 | 0.030 |
Why?
|
Algorithms | 1 | 2016 | 14033 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 4580 | 0.030 |
Why?
|
Antigens, CD | 1 | 2005 | 4001 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2005 | 3032 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2020 | 1363 | 0.030 |
Why?
|
Toll-Like Receptor 2 | 1 | 2015 | 347 | 0.030 |
Why?
|
Endosomes | 1 | 2015 | 522 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2015 | 579 | 0.020 |
Why?
|
Binding Sites | 1 | 2020 | 6056 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2020 | 12794 | 0.020 |
Why?
|
Prospective Studies | 1 | 2015 | 54423 | 0.020 |
Why?
|
Histones | 1 | 2020 | 2580 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
HLA-A2 Antigen | 1 | 2010 | 211 | 0.020 |
Why?
|
Protein Transport | 1 | 2015 | 1967 | 0.020 |
Why?
|
Poly I-C | 1 | 2009 | 112 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5790 | 0.020 |
Why?
|
Antigens, CD7 | 1 | 2008 | 29 | 0.020 |
Why?
|
L-Selectin | 1 | 2008 | 209 | 0.020 |
Why?
|
Immunoglobulin Fragments | 1 | 2008 | 84 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9353 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2015 | 64685 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2015 | 18966 | 0.020 |
Why?
|
Humans | 7 | 2020 | 761596 | 0.020 |
Why?
|
Immunoglobulin Variable Region | 1 | 2008 | 419 | 0.020 |
Why?
|
Vaccinia virus | 1 | 2008 | 331 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7593 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4281 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2010 | 823 | 0.020 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2005 | 221 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 2009 | 1206 | 0.010 |
Why?
|
Mice, Transgenic | 2 | 2008 | 9542 | 0.010 |
Why?
|
Oligopeptides | 1 | 2009 | 1187 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2008 | 1827 | 0.010 |
Why?
|
Mice, SCID | 1 | 2008 | 2626 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4576 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5035 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2206 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2009 | 14417 | 0.010 |
Why?
|
Virus Replication | 1 | 2009 | 2435 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3733 | 0.010 |
Why?
|
Mice | 4 | 2009 | 81539 | 0.010 |
Why?
|
Adult | 1 | 2015 | 221210 | 0.010 |
Why?
|
Signal Transduction | 2 | 2015 | 23447 | 0.010 |
Why?
|
RNA, Viral | 1 | 2008 | 2846 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2005 | 1251 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2008 | 22174 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2010 | 5112 | 0.010 |
Why?
|
Peptides | 1 | 2009 | 4358 | 0.010 |
Why?
|
Male | 1 | 2015 | 360846 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 6214 | 0.010 |
Why?
|
Animals | 4 | 2009 | 168475 | 0.010 |
Why?
|
Female | 1 | 2015 | 392705 | 0.010 |
Why?
|
Macrophages | 1 | 2009 | 5767 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2010 | 10451 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5485 | 0.010 |
Why?
|
Apoptosis | 1 | 2010 | 9490 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11076 | 0.010 |
Why?
|
HIV-1 | 1 | 2008 | 6863 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16592 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18255 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2005 | 11530 | 0.000 |
Why?
|